PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 20 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous extract showed a powerful inhibitory action on calcium oxalate monohydrate growth and aggregation in vitro [PMID:31238335].
Extract demonstrated high superoxide and nitric oxide radical scavenging activity [PMID:25649168].
Extracts were examined for cytotoxicity, anticancer activity, and antibacterial potential in vitro [PMID:34070269].
Evidence summary
PubMed sources
- 1.PMID: 34201481 (2021) — Rehydration Process in Rustyback Fern (Asplenium ceterach L.): Profiling of Volatile Organic Compounds. · Biology
- 2.PMID: 34070269 (2021) — Selective Anticancer Properties, Proapoptotic and Antibacterial Potential of Three Asplenium Species. · Plants (Basel, Switzerland)
- 3.PMID: 25649168 (2015) — Antioxidant activity of some Turkish medicinal plants. · Natural product research
- 4.PMID: 31238335 (2019) — In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism. · PloS one
- 5.PMID: 33823097 (2021) — Receptor-mediated biological effects of extracts obtained from three Asplenium species.